- Home
- YTRA vs KPTI Comparison
YTRA vs KPTI Comparison
Compare YTRA & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YTRA
- KPTI
- Stock Information
- Founded
- YTRA 2005
- KPTI 2008
- Country
- YTRA India
- KPTI United States
- Employees
- YTRA N/A
- KPTI N/A
- Industry
- YTRA Transportation Services
- KPTI Biotechnology: Pharmaceutical Preparations
- Sector
- YTRA Consumer Discretionary
- KPTI Health Care
- Exchange
- YTRA Nasdaq
- KPTI Nasdaq
- Market Cap
- YTRA 43.3M
- KPTI 44.5M
- IPO Year
- YTRA N/A
- KPTI 2013
- Fundamental
- Price
- YTRA $1.50
- KPTI $6.25
- Analyst Decision
- YTRA Strong Buy
- KPTI Buy
- Analyst Count
- YTRA 1
- KPTI 6
- Target Price
- YTRA $3.00
- KPTI $39.80
- AVG Volume (30 Days)
- YTRA 185.0K
- KPTI 213.1K
- Earning Date
- YTRA 08-08-2025
- KPTI 11-04-2025
- Dividend Yield
- YTRA N/A
- KPTI N/A
- EPS Growth
- YTRA N/A
- KPTI N/A
- EPS
- YTRA N/A
- KPTI N/A
- Revenue
- YTRA $104,960,625.00
- KPTI $137,269,000.00
- Revenue This Year
- YTRA N/A
- KPTI $3.67
- Revenue Next Year
- YTRA N/A
- KPTI $9.40
- P/E Ratio
- YTRA N/A
- KPTI N/A
- Revenue Growth
- YTRA 117.71
- KPTI N/A
- 52 Week Low
- YTRA $0.58
- KPTI $3.51
- 52 Week High
- YTRA $1.75
- KPTI $16.95
- Technical
- Relative Strength Index (RSI)
- YTRA 78.40
- KPTI 53.37
- Support Level
- YTRA $1.36
- KPTI $6.64
- Resistance Level
- YTRA $1.48
- KPTI $7.17
- Average True Range (ATR)
- YTRA 0.06
- KPTI 0.66
- MACD
- YTRA -0.00
- KPTI -0.07
- Stochastic Oscillator
- YTRA 79.82
- KPTI 28.57
About YTRA Yatra Online Inc.
Yatra Online Inc is an Indian consumer travel platform provider and online travel agent. The company is organized into the following business segments; Air Ticketing which derives maximum revenue, Hotels and Packages, and Other Services. It mainly provides travel-related services, which include domestic and international air ticketing, hotel bookings, homestays, holiday packages, bus ticketing, rail ticketing, activities and ancillary services. It also involves hosting advertisements on its internet websites, the sale of rail and bus tickets, and facilitating website access to travel insurance companies. Some of its applications include Yatra Mini, Yatra Web Check-In, Yatra Corporate, and Travelguru HomeStay.
About KPTI Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.